Quantcast
Newsday newsday.com 25 Nov, 2021 17:00 am

LI test maker wins $2.7 million judgment against UK firm that stole HIV self-test technology

LI test maker wins $2.7 million judgment against UK firm that stole HIV self-test technology
A Hauppauge manufacturer of HIV tests has won a $2.7 million judgment against a former distributor in the United Kingdom. Chembio Diagnostics Inc. said this week that an arbitration tribunal found its

said this week that an arbitration tribunal found its trade secrets for an HIV self-test were "misappropriated" by BioSure Ltd.That test, BioSure HIV Self-Test, was recognized by Queen Elizabeth II in April with the Queen’s Award for Enterprise: Innovation.At the time, BioSure CEO Bridgette Bard said its test "launched in 2015 as the world’s first approved blood-based HIV self-test." The arbitration tribunal has ordered BioSure to "stop making, using, offering for sale or selling the BioSure HIV Self-Test," Chembio said on Monday.

BioSure must transfer all regulatory approvals for its HIV test to Chembio and stop using the BioSure HIV Self-Test name, Chembio said.In 2014-19, BioSure was authorized to sell Chembio’s Sure Check HIV Self-Test in the United Kingdom.

Read full story at newsday.com